Selecting drug regimens in human leukemia
Hall, T.C.
National Cancer Institute Monograph 34: 145-151
1971
ISSN/ISBN: 0083-1921 PMID: 5291098 Document Number: 32536
Document emailed within 1 workday
Related Documents
Lerede, T.; Bassan, R.; Rossi, A.; Di Bona, E.; Rossi, G.; Pogliani, E.M.; Motta, T.; Torri, V.; Buelli, M.; Comotti, B.; Viero, P.; Rambaldi, A.; Cortelazzo, S.; Rodeghiero, F.; Barbui, T. 1996: Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma Haematologica 81(5): 442-449Siepler, J.K.; Mowers, R.M.; Trudeau, W.L. 1990: Selecting drug therapy for patients with duodenal ulcers Clinical Pharmacy 9(6): 463-467
Cairo, M.S.; Toy, C.; Sender, L.; Bennetts, G.; van de Ven, C. 1990: Combination chemotherapy and verapamil to purge drug resistant leukemia cells from human bone marrow Progress in Clinical and Biological Research 333: 47-55
Madon, E.; Pastore, G.; Cordero Di Montezemolo, L.; Grazia, G.; Brach Del Prever, A. 1983: The use of differentiated regimens in therapy of children with acute lymphoblastic leukemia Haematologica 68(1): 87-96
Borbolla-Escoboza, J.R.; López-Hernández, M.A.; González-Avante, M.; DeDiego, J.; Trueba-Christy, E.; Anaya-Cuéllar, I. 1998: Comparison of 2 regimens of polychemotherapy in refractory acute leukemia or in relapse Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 50(4): 307-310
Seon, B.K. 1984: Specific killing of human T-leukemia cells by immunotoxins prepared with ricin a chain and monoclonal anti-human T-cell leukemia antibodies Cancer Research 44(1): 259-264
Schwartz, E.L.; Brown, B.J.; Nierenburg, M.; Marsh, J.C.; Sartorelli, A.C. 1983: Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation Cancer Research 43(6): 2725-2730
Storb, R. 1993: Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantation Leukemia 7(Suppl 2): S135-S137
Sasaki, H.; Maekawa, I.; Kawamura, S.; Miyake, T. 1983: Comparative evaluation of combined chemotherapeutic regimens in acute non-lymphocytic leukemia Hokkaido Journal of Medical Science 58(3): 271-278
Herranz, J.é L. 2012: Selecting the first drug in children and adolescents with epilepsy: evidence versus personal experience Revista de Neurologia 54(Suppl 3): S1-S5
Duraj, J.; Takacsova, X.; Sedlak, J.; Sulikova, M.; Hunakova, L.; Bies, J.; Chorvath, B. 2000: PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant Anticancer Research 20(6b): 4627-4632
Mitulescu, D.; Selaru, D.; Ocian, R. 1999: Drug therapy regimens in diabetic retinopathy Oftalmologia 46(1): 63-66
Meliksetian, M.B.; Berezkina, E.V.; Pavlenko, M.A.; Grinchuk, T.M. 1999: Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase Ii inhibitors adriamycin and etoposide Tsitologiia 41(7): 615-621
Majlessipour, F.; Kwock, R.; Martin-Aragon, S.; Weinberg, K.I.; Avramis, V.I. 2001: Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities Anticancer Research 21(1a): 11-22
Crevasse, L.; Robinson, J.D.; Ariet, M.; Sung, J. 1988: A program for optimizing drug dosage regimens: digoxin M.D. Computing: Computers in Medical Practice 5(2): 27-35
Mah, J.T.; Wong, J.Y.; Lee, E.J. 2000: Pharmacogenetics: role in modifying drug dosage regimens Annals of the Academy of Medicine Singapore 29(5): 628-632
Bodey, G.P.; Coltman, C.A.; Hewlett, J.S.; Freireich, E.J. 1976: Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group Archives of Internal Medicine 136(12): 1383-1388
Waters, M.F. 1986: Concepts behind the development of multiple drug therapy regimens in leprosy Ethiopian Medical Journal 24(Suppl 1): 61-67
Nojiri, H.; Takaku, F.; Ohta, M.; Miura, Y.; Saito, M. 1985: Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60 Cancer Research 45(12 Pt 1): 6100-6106
Cabral, E.; Gomes Filho, J.M.; Gansl, R.C.; Silveira, P.A.; Menosi, S.F.; Zanichelli, M.A.; Tobos, K.; Pozzi, D. 1979: Acute lymphoblastic leukemia. Preliminary study of 2 therapeutic regimens, one without prophylactic radiotherapy of central nervous system involvement Revista do Hospital das Clinicas 34(5): 222-226